|
2025-03-12 |
2025-03-11 |
PS
Planned sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
18,020
-8.4%
23.61
USD 425,510
|
18,020
-8.4%
|
23.61
|
USD 425,510
|
|
|
2025-03-12 |
2025-03-11 |
PS
Planned sale
|
Davis John E
Chief Commercial Officer
Officer
|
15,100
-6.7%
23.61
USD 356,549
|
15,100
-6.7%
|
23.61
|
USD 356,549
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
1,048
-0.7%
24.80
USD 25,995
|
1,048
-0.7%
|
24.80
|
USD 25,995
|
|
|
2025-03-10 |
2025-03-06 |
PS
Planned sale
|
Mackin James P
President & CEO
Officer
|
70,700
-7.6%
24.76
USD 1,750,843
|
70,700
-7.6%
|
24.76
|
USD 1,750,843
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
17,739
-2.0%
24.80
USD 440,005
|
17,739
-2.0%
|
24.80
|
USD 440,005
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
2,124
-1.1%
24.80
USD 52,685
|
2,124
-1.1%
|
24.80
|
USD 52,685
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
2,618
-1.2%
24.80
USD 64,939
|
2,618
-1.2%
|
24.80
|
USD 64,939
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
1,603
-1.4%
24.80
USD 39,761
|
1,603
-1.4%
|
24.80
|
USD 39,761
|
|
|
2025-03-10 |
2025-03-06 |
S
Sale
|
Berry Lance A
Executive VP, CFO
Officer
|
4,909
-3.1%
24.80
USD 121,764
|
4,909
-3.1%
|
24.80
|
USD 121,764
|
|
|
2025-03-06 |
2025-03-05 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
472
-0.3%
25.29
USD 11,935
|
472
-0.3%
|
25.29
|
USD 11,935
|
|
|
2025-03-05 |
2025-03-05 |
B
Purchase
|
SEMEDO ANTHONY B.
Non-Executive Director
|
600
+inf%
25.25
USD 15,150
|
600
+inf%
|
25.25
|
USD 15,150
|
|
|
2025-03-05 |
2025-03-05 |
B
Purchase
|
SEMEDO ANTHONY B.
Non-Executive Director
|
1,500
+4.4%
25.33
USD 37,991
|
1,500
+4.4%
|
25.33
|
USD 37,991
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
485
-0.4%
27.31
USD 13,243
|
485
-0.4%
|
27.31
|
USD 13,243
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
318
-0.2%
27.31
USD 8,683
|
318
-0.2%
|
27.31
|
USD 8,683
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
814
-0.6%
27.31
USD 22,227
|
814
-0.6%
|
27.31
|
USD 22,227
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
1,706
-1.3%
27.31
USD 46,584
|
1,706
-1.3%
|
27.31
|
USD 46,584
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
4,896
-0.7%
27.31
USD 133,690
|
4,896
-0.7%
|
27.31
|
USD 133,690
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
6,812
-1.0%
27.31
USD 186,008
|
6,812
-1.0%
|
27.31
|
USD 186,008
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
13,784
-2.0%
27.31
USD 376,386
|
13,784
-2.0%
|
27.31
|
USD 376,386
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
16,664
-2.4%
27.31
USD 455,027
|
16,664
-2.4%
|
27.31
|
USD 455,027
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Berry Lance A
Executive VP, CFO
Officer
|
3,259
-4.1%
27.31
USD 88,990
|
3,259
-4.1%
|
27.31
|
USD 88,990
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
1,650
-1.1%
27.31
USD 45,055
|
1,650
-1.1%
|
27.31
|
USD 45,055
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
810
-0.5%
27.31
USD 22,118
|
810
-0.5%
|
27.31
|
USD 22,118
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
490
-0.3%
27.31
USD 13,380
|
490
-0.3%
|
27.31
|
USD 13,380
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
2,385
-1.5%
27.31
USD 65,125
|
2,385
-1.5%
|
27.31
|
USD 65,125
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
2,035
-1.3%
27.31
USD 55,568
|
2,035
-1.3%
|
27.31
|
USD 55,568
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
985
-0.6%
27.31
USD 26,896
|
985
-0.6%
|
27.31
|
USD 26,896
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
591
-0.4%
27.31
USD 16,138
|
591
-0.4%
|
27.31
|
USD 16,138
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
2,846
-1.7%
27.31
USD 77,713
|
2,846
-1.7%
|
27.31
|
USD 77,713
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
1,246
-1.5%
27.31
USD 34,023
|
1,246
-1.5%
|
27.31
|
USD 34,023
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
672
-0.8%
27.31
USD 18,350
|
672
-0.8%
|
27.31
|
USD 18,350
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
470
-0.6%
27.31
USD 12,834
|
470
-0.6%
|
27.31
|
USD 12,834
|
|
|
2025-02-26 |
2025-02-24 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
2,299
-2.7%
27.31
USD 62,776
|
2,299
-2.7%
|
27.31
|
USD 62,776
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
4,035
-2.6%
30.00
USD 121,050
|
4,035
-2.6%
|
30.00
|
USD 121,050
|
|
|
2024-12-12 |
2024-12-11 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
4,035
-2.5%
30.25
USD 122,059
|
4,035
-2.5%
|
30.25
|
USD 122,059
|
|
|
2024-12-09 |
2024-12-06 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
4,329
-3.1%
29.66
USD 128,398
|
4,329
-3.1%
|
29.66
|
USD 128,398
|
|
|
2024-12-04 |
2024-12-04 |
PS
Planned sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
7,618
-18.5%
30.00
USD 228,540
|
7,618
-18.5%
|
30.00
|
USD 228,540
|
|
|
2024-10-02 |
2024-10-01 |
PS
Planned sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
12,430
-8.2%
26.18
USD 325,415
|
12,430
-8.2%
|
26.18
|
USD 325,415
|
|
|
2024-08-27 |
2024-08-26 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
3,167
-1.9%
26.55
USD 84,096
|
3,167
-1.9%
|
26.55
|
USD 84,096
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Getz Matthew A
VP, Human Resources
Officer
|
2,562
-7.0%
25.31
USD 64,848
|
2,562
-7.0%
|
25.31
|
USD 64,848
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Getz Matthew A
VP, Human Resources
Officer
|
6,858
-15.8%
25.31
USD 173,586
|
6,858
-15.8%
|
25.31
|
USD 173,586
|
|
|
2024-08-16 |
2024-08-15 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
2,383
-1.4%
25.76
USD 61,393
|
2,383
-1.4%
|
25.76
|
USD 61,393
|
|
|
2024-08-15 |
2024-08-13 |
S
Sale
|
SEMEDO ANTHONY B.
Non-Executive Director
|
9,709
-22.1%
24.99
USD 242,628
|
9,709
-22.1%
|
24.99
|
USD 242,628
|
|
|
2024-05-13 |
2024-05-10 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
1,250
-0.7%
23.42
USD 29,275
|
1,250
-0.7%
|
23.42
|
USD 29,275
|
|
|
2024-05-10 |
2024-05-09 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
979
-0.6%
23.79
USD 23,286
|
979
-0.6%
|
23.79
|
USD 23,286
|
|
|
2024-05-10 |
2024-05-09 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
979
-0.6%
23.79
USD 23,286
|
979
-0.6%
|
23.79
|
USD 23,286
|
|
|
2024-03-21 |
2024-03-20 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
2,183
-2.6%
20.39
USD 44,511
|
2,183
-2.6%
|
20.39
|
USD 44,511
|
|
|
2024-03-18 |
2024-03-15 |
PS
Planned sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
1,462
-3.4%
20.00
USD 29,240
|
1,462
-3.4%
|
20.00
|
USD 29,240
|
|
|
2024-03-15 |
2024-03-14 |
PS
Planned sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
3,994
-8.6%
20.00
USD 79,880
|
3,994
-8.6%
|
20.00
|
USD 79,880
|
|
|
2024-03-14 |
2024-03-12 |
S
Sale
|
Getz Matthew A
VP, Human Resources
Officer
|
5,000
-10.3%
19.94
USD 99,720
|
5,000
-10.3%
|
19.94
|
USD 99,720
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Getz Matthew A
VP, Human Resources
Officer
|
1,157
-2.3%
18.72
USD 21,661
|
1,157
-2.3%
|
18.72
|
USD 21,661
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Maney Rochelle L.
VP, Quality
Officer
|
1,157
-2.4%
18.72
USD 21,662
|
1,157
-2.4%
|
18.72
|
USD 21,662
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
1,506
-1.7%
18.72
USD 28,195
|
1,506
-1.7%
|
18.72
|
USD 28,195
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
2,380
-1.4%
18.72
USD 44,559
|
2,380
-1.4%
|
18.72
|
USD 44,559
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
13,996
-1.9%
18.72
USD 262,037
|
13,996
-1.9%
|
18.72
|
USD 262,037
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
2,022
-1.2%
18.72
USD 37,856
|
2,022
-1.2%
|
18.72
|
USD 37,856
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
1,152
-0.8%
18.72
USD 21,568
|
1,152
-0.8%
|
18.72
|
USD 21,568
|
|
|
2024-03-07 |
2024-03-05 |
S
Sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
1,160
-2.4%
18.72
USD 21,718
|
1,160
-2.4%
|
18.72
|
USD 21,718
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
465
-0.6%
19.83
USD 9,223
|
465
-0.6%
|
19.83
|
USD 9,223
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Horton Amy
VP, Chief Accounting Officer
Officer
|
325
-0.2%
19.83
USD 6,446
|
325
-0.2%
|
19.83
|
USD 6,446
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Holloway Jean F
SVP, General Counsel
Officer
|
485
-0.3%
19.83
USD 9,620
|
485
-0.3%
|
19.83
|
USD 9,620
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Tyrs Florian
VP, Global Operations
Officer
|
339
-1.5%
19.83
USD 6,724
|
339
-1.5%
|
19.83
|
USD 6,724
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
4,837
-0.7%
19.83
USD 95,939
|
4,837
-0.7%
|
19.83
|
USD 95,939
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Getz Matthew A
VP, Human Resources
Officer
|
325
-0.7%
19.83
USD 6,446
|
325
-0.7%
|
19.83
|
USD 6,446
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Maney Rochelle L.
VP, Quality
Officer
|
370
-0.8%
19.83
USD 7,339
|
370
-0.8%
|
19.83
|
USD 7,339
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
Davis John E
Chief Commercial Officer
Officer
|
584
-0.4%
19.83
USD 11,583
|
584
-0.4%
|
19.83
|
USD 11,583
|
|
|
2024-02-29 |
2024-02-27 |
S
Sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
421
-0.9%
19.83
USD 8,350
|
421
-0.9%
|
19.83
|
USD 8,350
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
1,448
-1.7%
20.27
USD 29,353
|
1,448
-1.7%
|
20.27
|
USD 29,353
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Stanton Marshall S.
SVP, Clinical & MD Affair
Officer
|
1,600
-2.2%
20.27
USD 32,434
|
1,600
-2.2%
|
20.27
|
USD 32,434
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
1,218
-2.7%
20.27
USD 24,690
|
1,218
-2.7%
|
20.27
|
USD 24,690
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
GREEN ANDREW M
VP Regulatory
Officer
|
1,185
-3.0%
20.27
USD 24,021
|
1,185
-3.0%
|
20.27
|
USD 24,021
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Maney Rochelle L.
VP, Quality
Officer
|
1,130
-2.5%
20.27
USD 22,906
|
1,130
-2.5%
|
20.27
|
USD 22,906
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Maney Rochelle L.
VP, Quality
Officer
|
1,185
-2.9%
20.27
USD 24,021
|
1,185
-2.9%
|
20.27
|
USD 24,021
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
13,168
-1.9%
20.27
USD 266,930
|
13,168
-1.9%
|
20.27
|
USD 266,930
|
|
|
2024-02-28 |
2024-02-26 |
S
Sale
|
Mackin James P
President & CEO
Officer
|
18,144
-2.7%
20.27
USD 367,799
|
18,144
-2.7%
|
20.27
|
USD 367,799
|
|
